Internal dosimetry monitoring equipment used in the successful measure
ment and assessment of internal exposures is highly dependent on effec
tive capabilities in the measurement of radioactive materials directly
and/or indirectly in the body. This capability must be supplemented b
y comprehensive field measurements to quantify materials (i.e. surface
and airborne contamination) in the workplace which become the source
of exposure to the workers. Because of current limitations on minimum
detectable activities or amounts for in vivo or in vitro measurements
for some radionuclides (i.e. poorly transported alpha emitters), a rou
tine bioassay programme which would maintain the potential minimum det
ectable dose to a few millisieverts committed effective dose equivalen
t (H(E.50)) would be prohibitively expensive to operate and unacceptab
le to the worker. Thus the operation of a strong field measurement pro
gramme to provide warning of possible intakes is extremely important t
o permit timely bioassay measurements to be performed within the limit
s of detection. The present and future capabilities of the three measu
rement programmes will be discussed together with the need to balance
research and development costs for new or improved measurement techniq
ues with the costs associated with improving knowledge as to the relat
ionship(s) between measurement and the amount present in various organ
s.